Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
Anaheim Clinical Trials, LLC, Anaheim, California Orange County Research Center, Lake Forest, California Diablo Clinical Research, Inc., Walnut Creek, California Miami Eye Institute, Hollywood, Florida Research Centers of America, Hollywood, Florida NYU Langone Health, New York, New York CTI Clinical Research Center, Cincinnati, Ohio Senders Pediatrics, South Euclid, Ohio Alliance for Multispecialty Research, LLC, Knoxville, Tennessee Alliance for Multispecialty Research, LLC, Knoxville, Tennessee University Eye Specialists, P.C. (Ophthalmologist), Maryville, Tennessee